Abstract: A support stand for photography includes a support main body having supporting ends and a mounting end and an adapting device provided at the mounting end. The supporting ends are formed on supporting legs of the support main body. The supporting legs can be unfolded to allow two adjacent supporting ends to move away from each other. The supporting legs can be folded to allow the two adjacent supporting ends to move close to each other and form a gap between two adjacent supporting legs. The adapting device includes a fixed seat provided with an adapting structure for mounting a first photographic equipment and a clamping seat configured to clamp a second photographic equipment. The clamping seat is rotatably connected to the fixed seat. The clamping seat can rotate toward a side where the supporting ends are located to be accommodated in the gap between the two adjacent supporting legs.

Abstract: A photography stand includes a central pipe and a supporting frame. The top of the central pipe is configured to mount photographic equipment. The supporting frame is connected to the central pipe, and provided adjacent to the bottom of the central pipe. The supporting frame moves relative to the central pipe along the axial direction of the central pipe. The supporting frame is unfolded when moving along the axial direction of the central pipe toward the bottom of the central pipe by a preset distance and then moving continuously toward the bottom of the central pipe. The supporting frame is folded when moving along the axial direction of the central pipe toward the top of the central pipe. According to the photography stand, the supporting frame is unfolded automatically after moving along the axial direction of the central pipe toward the bottom of the central pipe by the preset distance.

Abstract: A photography stand includes a central pipe and a supporting frame. The top of the central pipe is configured to mount photographic equipment. The supporting frame is connected to the central pipe, and provided adjacent to the bottom of the central pipe. The supporting frame moves relative to the central pipe along the axial direction of the central pipe. The supporting frame is unfolded when moving along the axial direction of the central pipe toward the bottom of the central pipe by a preset distance and then moving continuously toward the bottom of the central pipe. The supporting frame is folded when moving along the axial direction of the central pipe toward the top of the central pipe. According to the photography stand, the supporting frame is unfolded automatically after moving along the axial direction of the central pipe toward the bottom of the central pipe by the preset distance.

Abstract: Disclosed is a rapid solidification method of calcareous sand, and the method relates to the technical field of a calcareous sand reinforcement in island reef engineering. The specific method is to achieve a rapid solidification of the calcareous sand by applying a zinc sulfate solution to the calcareous sand.

Abstract: Provided are a mutated nucleic acid molecule of a recombinant human-basic fibroblast growth factor (rh-bFGF), a pharmaceutical composition of the rh-bFGF, and a use thereof.

Abstract: Provided are a method for producing a soluble recombinant human-basic fibroblast growth factor (rh-bFGF), a recombinant human-basic fibroblast growth factor (rh-bFGF) obtained by the method, and a mutated nucleic acid molecule encoding the recombinant human-basic fibroblast growth factor (rh-bFGF).

Abstract: Provided are a mutated nucleic acid molecule of a recombinant human-basic fibroblast growth factor (rh-bFGF), a pharmaceutical composition of the rh-bFGF, and a use thereof.

Abstract: Provided are a method for producing a soluble recombinant human-basic fibroblast growth factor (rh-bFGF), a recombinant human-basic fibroblast growth factor (rh-bFGF) obtained by the method, and a mutated nucleic acid molecule encoding the recombinant human-basic fibroblast growth factor (rh-bFGF).

Abstract: Provided are an organic rare-earth solid micelle, a preparation method therefor, and a method for increasing the photoelectric conversion efficiency of a solar battery. A small organic conjugated ligand is taken as a first ligand, an amphiphilic diblock polymer is taken as a second ligand, and the first ligand and the second ligand are mixed and doped with a rare-earth chloride solution, and self-assembled to form an organic rare-earth solid micelle, whereby the fluorescence emission intensity and the fluorescence efficiency of the rare-earth element are improved. Next, the prepared organic rare-earth solid micelle is spin coated on an ITO layer of a solar battery, to prepare a solar battery with the organic rare-earth solid micelle. Therefore the sunlight absorption of a cell is increased, and the photoelectric conversion efficiency is improved. The preparation process is simple, low in cost, high in photoelectric conversion efficiency, and environmentally friendly.

Abstract: The present invention relates to antibodies which specifically bind vascular endothelial growth factor (VEGF), in particular heavy-chain antibodies, and more particularly single-domain antibodies. The present invention also relates to a method of producing the antibodies and the therapeutic uses thereof.

Abstract: Provided are an organic rare-earth solid micelle, a preparation method therefor, and a method for increasing the photoelectric conversion efficiency of a solar battery. A small organic conjugated ligand is taken as a first ligand, an amphiphilic diblock polymer is taken as a second ligand, and the first ligand and the second ligand are mixed and doped with a rare-earth chloride solution, and self-assembled to form an organic rare-earth solid micelle, whereby the fluorescence emission intensity and the fluorescence efficiency of the rare-earth element are improved. Next, the prepared organic rare-earth solid micelle is spin coated on an ITO layer of a solar battery, to prepare a solar battery with the organic rare-earth solid micelle. Therefore the sunlight absorption of a cell is increased, and the photoelectric conversion efficiency is improved. The preparation process is simple, low in cost, high in photoelectric conversion efficiency, and environmentally friendly.

Abstract: The present invention relates to antibodies which specifically bind vascular endothelial growth factor (VEGF), in particular heavy-chain antibodies, and more particularly single-domain antibodies. The present invention also relates to a method of producing the antibodies and the therapeutic uses thereof.